Albert H. Kim (@alberthkimmdphd) 's Twitter Profile
Albert H. Kim

@alberthkimmdphd

Director, The Brain Tumor Center, @WashUBTC @WashUNeurosurg @WUSTLmed @BarnesJewish @SitemanCenter WashU Medicine

ID: 989303216042102784

calendar_today26-04-2018 00:40:41

491 Tweet

2,2K Followers

992 Following

Bo Bigelow (@bobigelow) 's Twitter Profile Photo

Thrilled about this preprint article from Hao Chen & Albert Kim, MD, PhD about USP7 and Hao-Fountain syndrome! You guys had me at "a novel p53-independent ubiquitin signaling pathway." ncbi.nlm.nih.gov/pmc/articles/P… Albert H. Kim Test Account #USP7 #HaoFountainsyndrome Hao-Fountain Syndrome

Thrilled about this preprint article from Hao Chen &amp; Albert Kim, MD, PhD about USP7 and Hao-Fountain syndrome! You guys had me at "a novel p53-independent ubiquitin signaling pathway." ncbi.nlm.nih.gov/pmc/articles/P…  <a href="/AlbertHKimMDPhD/">Albert H. Kim</a> <a href="/WUSTLmed/">Test Account</a> #USP7 #HaoFountainsyndrome <a href="/FoundationUSP7/">Hao-Fountain Syndrome</a>
RaleighLab (@labraleigh) 's Twitter Profile Photo

VERY happy to share THREE papers exploring the genomic, biochemical, and cellular architecture of Schwann cell tumors published in Nature Communications today from RaleighLab members John Liu, MD PhD and Tim Casey-Clyde, from former lab member Vasudevan Lab, and from Albert H. Kim! 1/5

RaleighLab (@labraleigh) 's Twitter Profile Photo

First, RaleighLab shows that functional interactions between neurofibromatosis tumor suppressors underlies Schwann cell tumor de-differentiation and treatment resistance, revealing new therapeutic strategies for resistant tumors. 2/5 nature.com/articles/s4146…

RaleighLab (@labraleigh) 's Twitter Profile Photo

Third, RaleighLab shows that epigenetic reprogramming shared the cellular landscape of schwannomas, and reports a novel function genomic technique for single-nuclei RNA/ATAC/CRISPRi-perturbation sequencing (snARC-seq). 4/5 nature.com/articles/s4146…

RaleighLab (@labraleigh) 's Twitter Profile Photo

In sum, many advances in our understanding of these common peripheral nervous system tumors, and some new techniques with broad relevance ! Exhilarating to work with Vasudevan Lab John Liu, MD PhD Tim Casey-Clyde Albert H. Kim and many others on these papers! UCSF Neurosurgery . 5/5

WashU Med Taylor Family Department of Neurosurgery (@washuneurosurg) 's Twitter Profile Photo

Repetitive sequences make up much of the human genome and have been implicated in #cancer development. In the latest edition of Science Magazine, Dr. Dimitrios Mathios (Dimitrios Mathios) and colleagues (1/2)

The Brain Tumor Center (@washumedbtc) 's Twitter Profile Photo

The #BrainTumorCenter seminar series is back! Join us on 4/3 at 8:30 a.m. CST for a talk by Aaron Diaz, PhD (Diaz Laboratory) about single-cell studies of #braintumor heterogeneity. Siteman Cancer Center Test Account

The #BrainTumorCenter seminar series is back! Join us on 4/3 at 8:30 a.m. CST for a talk by Aaron Diaz, PhD (<a href="/diazlaboratory/">Diaz Laboratory</a>) about single-cell studies of #braintumor heterogeneity. <a href="/SitemanCenter/">Siteman Cancer Center</a> <a href="/WUSTLmed/">Test Account</a>
The Brain Tumor Center (@washumedbtc) 's Twitter Profile Photo

The #BrainTumorCenter seminar series welcomes Christine Brown, PhD, from City of Hope as she discusses "CAR T Cells for #Glioblastoma. Join us in Moore Auditorium on 5/1 at 8:30 a.m. for breakfast & conversation. Siteman Cancer Center

The #BrainTumorCenter seminar series welcomes Christine Brown, PhD, from <a href="/cityofhope/">City of Hope</a> as she discusses "CAR T Cells for #Glioblastoma. Join us in Moore Auditorium on 5/1 at 8:30 a.m. for breakfast &amp; conversation. <a href="/SitemanCenter/">Siteman Cancer Center</a>
Siteman Cancer Center (@sitemancenter) 's Twitter Profile Photo

Today is World Brain Tumor Day, an opportunity to highlight the Brain Tumor Center at Siteman and the exceptional Test Account physicians and researchers who provide exceptional care grounded in cutting-edge research and clinical trials. Learn more: l8r.it/sPlS

Today is World Brain Tumor Day, an opportunity to highlight the Brain Tumor Center at Siteman and the exceptional <a href="/WUSTLmed/">Test Account</a> physicians and researchers who provide exceptional care grounded in cutting-edge research and clinical trials.

Learn more: l8r.it/sPlS
Organoid News (@organoidscience) 's Twitter Profile Photo

.Matthew Ishahak and team, including Jeffrey Millman & Albert H. Kim, developed engineered #glioblastoma (GBM) #organoids harboring GBM subtype-specific oncogenic mutations to study the underlying transcriptional regulation of tumor progression. 👉 bit.ly/4arbBBb

.<a href="/MattIshahak/">Matthew Ishahak</a> and team, including <a href="/JeffreyRMillman/">Jeffrey Millman</a> &amp; <a href="/AlbertHKimMDPhD/">Albert H. Kim</a>, developed engineered #glioblastoma (GBM) #organoids harboring GBM subtype-specific oncogenic mutations to study the underlying transcriptional regulation of tumor progression. 

👉 bit.ly/4arbBBb
Albert H. Kim (@alberthkimmdphd) 's Twitter Profile Photo

Please check out our collaborative meningioma paper with Akash Patel helmed by Bhuvic Patel, MD Sangami Pugazenthi on the molecular basis of radiation resistance in necrotic grade 2 meningiomas. Great job, team! academic.oup.com/jnci/advance-a…

Albert H. Kim (@alberthkimmdphd) 's Twitter Profile Photo

Congrats to Julie M Silverstein, Medical Director-WashU Pituitary Center, and team The Brain Tumor Center on randomized trial that definitively shows fluid restriction after endoscopic endonasal surgery for pituitary tumors decreases the most common post op complication. Neuro-Oncology now!